je.st
news
Tracking Dan Loeb's Third Point Portfolio - Q4 2014 Update
2015-02-17 12:02:08| Biotech - Topix.net
Loeb's 13F portfolio increased ~27% this quarter from $8.71B to $11.09B. The number of positions decreased from 41 to 40. Third Point substantially increased large stakes in Actavis plc, Alibaba Group, Amgen Inc., and eBay Inc. while reducing Dow Chemical and Ally Financial.
Tags: point
update
dan
portfolio
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||